Cretostimogene grenadenorepvec
Term · Oncology and biomedicine · MLC-T-ONC-012802
A recombinant oncolytic adenovirus encoding the immunohematopoietic cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with potential antineoplastic activity. Upon administration, cretostimogene grenadenorepvec selectively infects and replicates in tumor cells, which may result in tumor cells lysis. Synergistically, GM-CSF expressed by the oncolytic adenovirus may promote a cytotoxic T cell response against tumor cells harboring the oncolytic adenovirus, resulting in an immune-mediated tumor cell death.
| Identifier | MLC-T-ONC-012802 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | oncolytic adenovirus encoding GM-CSF |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012802",
"term": "Cretostimogene grenadenorepvec",
"field": "Oncology and biomedicine",
"definition": "A recombinant oncolytic adenovirus encoding the immunohematopoietic cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with potential antineoplastic activity. Upon administration, cretostimogene grenadenorepvec selectively infects and replicates in tumor cells, which may result in tumor cells lysis. Synergistically, GM-CSF expressed by the oncolytic adenovirus may promote a cytotoxic T cell response against tumor cells harboring the oncolytic adenovirus, resulting in an immune-mediated tumor cell death.",
"synonyms": [
"oncolytic adenovirus encoding GM-CSF"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cretostimogene-grenadenorepvec/"
}
Record 5,426 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.